Reviva Pharmaceuticals Announced Preclinical Efficacy Data on Brilaroxazine in IPF at the 2023 American Thoracic Society International Conference and Publication in Medical Research Archives - Yahoo Finance

ICVXDelisted Stock  USD 9.02  0.12  1.31%   
Slightly above 62% of Icosavax's investor base is looking to short. The analysis of current outlook of investing in Icosavax suggests that many traders are alarmed regarding Icosavax's prospects. Icosavax's investing sentiment can be driven by a variety of factors including economic data, Icosavax's earnings reports, geopolitical events, and overall market trends.
  
Reviva Pharmaceuticals Announced Preclinical Efficacy Data on Brilaroxazine in IPF at the 2023 American Thoracic Society International Conference and Publication in Medical Research Archives Yahoo Finance

Read at news.google.com
Google News at Macroaxis
  

Icosavax Fundamental Analysis

We analyze Icosavax's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Icosavax using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Icosavax based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Short Ratio

Short Ratio Comparative Analysis

Icosavax is currently under evaluation in short ratio category among its peers. Short Ratio is typically used by traders and speculators to identify trends in current market sentiment for a particular equity instrument. In its simple terms this ratio shows how many days it will take all current short sellers to cover their positions if the price of a stock begins to rise.

Icosavax Potential Pair-trading

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Icosavax stock to make a market-neutral strategy. Peer analysis of Icosavax could also be used in its relative valuation, which is a method of valuing Icosavax by comparing valuation metrics with similar companies.

Peers

Icosavax Related Equities

XFORX4 Pharmaceuticals   11.43   
0%
100.0%
ELDNEledon Pharmaceuticals   9.39   
0%
82.0%
IMMXImmix Biopharma   7.11   
0%
62.0%
HEPAHepion Pharmaceuticals   4.69   
0%
41.0%
PDSBPDS Biotechnology   1.86   
0%
16.0%
HOOKHookipa Pharma   1.61   
0%
14.0%
DAWNDay One   1.53   
0%
13.0%
MREOMereo BioPharma   1.40   
0%
12.0%
ABOSAcumen Pharmaceuticals   0.44   
0%
3.0%
INZYInozyme Pharma   0.37   
3.0%
0%
TERNTerns Pharmaceuticals   1.58   
13.0%
0%
AMLXAmylyx Pharmaceuticals   3.48   
30.0%
0%
CNSPCns Pharmaceuticals   8.33   
72.0%
0%
Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real.
You can also try the Investing Opportunities module to build portfolios using our predefined set of ideas and optimize them against your investing preferences.

Other Consideration for investing in Icosavax Stock

If you are still planning to invest in Icosavax check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Icosavax's history and understand the potential risks before investing.
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
FinTech Suite
Use AI to screen and filter profitable investment opportunities
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Bonds Directory
Find actively traded corporate debentures issued by US companies